Journal of the American Academy of Dermatology
Volume 39, Issue 6 , Pages 971-974 , December 1998

Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa

References 

  1. Highet AS, Hay RJ, Roberts SOB. Bacterial infections. In:  Champion RH,  Burton JL,  Ebling FJG editor. Textbook of dermatology. Oxford: Blackwell Scientific Publications; 1992;p. 953–1031
  2. Jemec GBE, Faber M, Gutschick E, et al.  Microbiology of hidradenitis suppurativa. Dermatology. 1996;193:203–206
  3. Clemmensen OJ. Topical treatment of hidradenitis suppurativa with topical clindamycin. Int J Dermatol. 1983;22:325–328
  4. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurative, and familial benign pemphigus: surgical approach. In:  Roenigk RK,  Roenigk HHJ editor. Dermatologic surgery: principles and practice. New York: Marcel Dekker; 1989;p. 717–743
  5. Simpson N. Effect of isotretinoin on the quality of life in patients with acne. Pharmacoeconomics. 1994;6:108–113
  6. Jemec GBE, Wulf HC. Patient-doctor consensus on quality-of-life in dermatology. Clin Exp Dermatol. 1996;21:177–179
  7. Jemec GBE, Heidenheim M, Nielsen NH. Hidradenitis suppurativa: characteristics and consequences. Clin Exp Dermatol. 1996;21:419–423

☆ Reprint requests: Gregor B. E. Jemec, Strandvejen 97, 3.tv., DK-2900 Hellerup, Denmark.

☆☆ 0190-9622/98/$5.00 + 0  16/1/93688

PII: S0190-9622(98)70272-5

Journal of the American Academy of Dermatology
Volume 39, Issue 6 , Pages 971-974 , December 1998

Article Tools

* Image Usage & Resolution